Phase 2 Start~month

Phase 2 Start: A First-in-Human, Multicenter, Phase 1/2, Open-Label Study of XTX501 in Participants With Metastatic

XLO overview →Track this catalyst
Drug
xtx501
Indication
Advanced Solid Tumor; Metastatic NSCLC - Non-Small Cell Lung Cancer

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Start: A First-in-Human, Multicenter, Phase 1/2, Open-Label Study of XTX501 in Participants With Metastatic — XLO Phase 2 Start | BioSniper